ArticleBioscience reports2018

GCN5 inhibition prevents IL-6-induced prostate cancer metastases through PI3K/PTEN/Akt signaling by inactivating Egr-1.

Guangfeng Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.